Gout ๐ฆถ Flashcards
Define Gout
Inflammatory arthiritis
Rheumatic condition with symptoms of joint pain, swelling and redness.
What is the major risk factor for Gout
Hyperuricaemia
What is hyperuricaemia?
How does it occur?
Deposition of urate crystals in and around thr joints
Occurs when there is increase synthesis of purine precursors of urine and and/or decrease renal elimination of uric acid.
Risk Factors for Gout
Age
Male sex
Diet > purine rich foods
Reduced renal excretion = concomitant meds OR obesity OR renal impairment
Genetics
Pathophysiology of Gout
Disorder or purine metabolism, where uric acid is thr product
Overproduction of uric acid
Underexcretion of uric acid
Diagnostic features of GOUT
Features:
- Articular involvement
- Rapid onset of severe pain and swelling
- Erythema
- Male gender
Treatment of Gout
NON PHARMACOLOGICAL
- Avoid dietary triggers
- Reduce alcohol consumption
- Keep hydrated
- Implement weight loss program
Treatment of Gout
PHARMACOLOGICAL =
GOUT FLARES
First line = NSAIDS, Colchicine
Second line = corticosteroids
Advice for corticosteroid INTRA ARTICULAR INJ
- Donโt give > 4 inj / year into an single joint = risk of cartilage damage
- Avoid future inj if there is no response after 2 consecutive inj
- Dont give inj to big toe = painful
Indications of use for
Prophylatic treatment
- Tophaceous Gout
- Evidence of radiographic damage attributable to Gout
- 2 or more Gout flare per year
Classes and names of Urate Lowering Therapy
- XANTHINE OXIDASE INHIBITORS
= Reduce production of uric acid
> Allopurinol
Febuxostat
- URICOSURIC AGENTS
= Increase the renal clearance of uric acid
> Probenecid
Targets for intervention in treatment and prophylaxis of Gout
Diagram
Target to treat approach:
Aim: keep serum urate concentrations <0.36 mmol/L.
Continue urate lowering therapy INDEFINITELY.
Allopurinol
Safety and counselling points
Risk of Allopurinol hypersensitivity syndrome is increases in carriers of HLA-B*5801
AVOID!!
Fubuxostat
Safety and counselling points
Eligible only if Allopurinol contraindicated/intolerance
Appropriate in HLA-B5801 positive patients
**Risk of cardiovascular death
Probenecid
Safety and counselling points
Not recommended in patients with mod to severe CKD
Avoid if crcl <10ml/min
**Risk of drug drug interactions